{"id":823376,"date":"2026-07-24T16:02:13","date_gmt":"2026-07-24T16:02:13","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/823376\/"},"modified":"2026-07-24T16:02:13","modified_gmt":"2026-07-24T16:02:13","slug":"pharmalittle-fda-panel-backs-pharmacies-to-make-peptides","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/823376\/","title":{"rendered":"Pharmalittle: FDA panel backs pharmacies to make peptides"},"content":{"rendered":"

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still in the works, but we do plan to promenade extensively with the official mascots, stroll the supermarket aisles, and spend time with the Pharmalot ancestor. We also hope to hold yet another listening party, where the rotation will likely include this<\/a>, this<\/a>, this<\/a>, this<\/a> and this<\/a>. And what about you? The possibilities are endless \u2014 you could stop by your favorite restaurant, curl up with a good book, hang with your best friend, or take a long drive to nowhere. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. \u2026<\/p>\n

In a win for peptide proponents and for U.S. Health and Human Services Secretary Robert F. Kennedy Jr., an advisory panel to the U.S. Food and Drug Administration recommended compounding pharmacies be allowed to make the drugs BPC-157, KPV, TB-500, and MOTS-c., STAT<\/a> says The FDA panel will vote on additional compounds on Friday. The votes are not binding, so the FDA will decide whether to lift restrictions and make them more accessible to people who have been turning to the little-researched but popular drugs. The vote reflects tensions\u00a0between FDA staff, who recommended against lifting restrictions on the peptides because of safety and efficacy concerns, and the panel, which critics have said was \u201cstacked\u201d by Kennedy with people who stand to benefit\u00a0from broader peptide access.<\/p>\n

People with diabetes who use a popular long-acting insulin pen made by Sanofi have had to become pharmacy scouts in recent weeks as they encounter supply issues, STAT<\/a> explains. The Lantus Solostar pen containing 3 milliliters of insulin glargine has been running low for several weeks because of increased demand \u201cdriven by broader market dynamics,\u201d according to Sanofi. The issue is not technically considered a shortage by the FDA, but patients are having trouble finding the medication. While some diabetes patients have had luck finding the medication at small independent pharmacies or their hospital pharmacy, large pharmacies like CVS and Walgreens are coming up dry.<\/p>\n

STAT+ Exclusive Story<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\"STAT+\"\/<\/p>\n

\t\t\t\t\t
\n\t\t\t\t\t\t\"STAT+\"\/
\n\t\t\t\t\t<\/a><\/p>\n

\t\t\t\tThis article is exclusive to STAT+ subscribers
\n\t\t\t\tUnlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\t\t\tIndividual plans<\/p>\n

\t\t\t\t\t\tGroup plans<\/p>\n

\t\t\t\tView All Plans<\/a><\/p>\n

\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n

\t\t\t\t\tSubscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"And so, another working week will soon draw to a close. Not a moment too soon, yes? This…\n","protected":false},"author":2,"featured_media":12378,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[49,48,84,377,11715,2101],"class_list":["post-823376","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-ca","tag-canada","tag-health","tag-medication","tag-pharmalittle","tag-stat"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/823376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=823376"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/823376\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/12378"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=823376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=823376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=823376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}